Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0H4NQ
|
|||
| Former ID |
DIB005300
|
|||
| Drug Name |
AWD-5239
|
|||
| Synonyms |
N,N-Bis-(2-acetoxyethyl)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[5,4,3-fg]quinoline-9-carboxamide monotartrate; 6-Methylergoline-8-carboxylic acid bis(beta-acetoxyethyl)amide monotartrate; 9,10-Dihydrolysergic acid bis(beta-acetoxyethyl)amide monotartrate
Click to Show/Hide
|
|||
| Indication | Cognitive impairment [ICD-11: 6D71; ICD-10: F06.7] | Discontinued in Phase 2 | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800001326) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.